Takuya Masunaga
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Prognostic impact of immune-related adverse events in recurrent or metastatic sinonasal squamous cell carcinoma treated with immune checkpoint inhibitors.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: March 03, 2026
Inositol hexakisphosphate is a Cofactor and Modulator of ADAR1 RNA Editing Activity.
Journal: RNA (New York, N.Y.)
Published: February 16, 2026
Anticancer Activity of Liposomes Prepared Solely From Cardiolipin.
Journal: Lipids
Published: February 05, 2026
Hydrazonylthiazole Derivatives as Dual EGFR and ALR2 Inhibitors: Design, Synthesis, and Comprehensive In Vitro and In Silico Evaluation for Potential Anticancer Activity.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 26, 2025
A heterocyclic compound inhibits viral release by inducing cell surface BST2/Tetherin/CD317/HM1.24.
Journal: The Journal of biological chemistry
Published: May 31, 2024
A New Inhibitor of ADAM17 Composed of a Zinc-Binding Dithiol Moiety and a Specificity Pocket-Binding Appendage.
Journal: Chemical & pharmaceutical bulletin
Published: November 01, 2021
Anti-cancer activity of the cell membrane-permeable phytic acid prodrug.
Journal: Bioorganic chemistry
Published: May 23, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026